These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 3245531
1. [A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy]. Kondo K, Kamidono S, Hamami G. Hinyokika Kiyo; 1988 Oct; 34(10):1845-51. PubMed ID: 3245531 [Abstract] [Full Text] [Related]
2. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study]. Bartolucci F, Cecarini M, Gabrielli G, Abbiati R, Barberio M, Busilacchi P. Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455 [Abstract] [Full Text] [Related]
3. Delayed vs. immediate adverse reactions to ionic and non-ionic low-osmolality contrast media. Oi H, Yamazaki H, Matsushita M. Radiat Med; 1997 Oct; 15(1):23-7. PubMed ID: 9134581 [Abstract] [Full Text] [Related]
4. Acute and late adverse reactions to low-osmolal contrast media. Mikkonen R, Kontkanen T, Kivisaari L. Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173 [Abstract] [Full Text] [Related]
5. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation. Vijayalakshmi K, Kunadian B, Wright RA, Hall JA, Stewart MJ, Davies A, Sutton A, de Belder MA. Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256 [Abstract] [Full Text] [Related]
8. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy. Danzi GB, Capuano C, Sesana M, Predolini S, Baglini R. Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424 [Abstract] [Full Text] [Related]
13. The delayed adverse reactions of low osmolar contrast media. Higashi TS, Katayama M. Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Nov 25; 50(11):1359-66. PubMed ID: 2087395 [Abstract] [Full Text] [Related]
14. [Adverse effects of a new non-ionic contrast medium in heart catheterization]. Meyer GP, Trappe HJ, Jost S, Rafflenbeul W, Wenzlaff P, Lichtlen P. Arzneimittelforschung; 1993 Aug 25; 43(8):932-4. PubMed ID: 8216457 [Abstract] [Full Text] [Related]
15. [Must the patient fast before intravascular injection of a non-ionic contrast medium? Results of a controlled study]. Wagner HJ, Evers JP, Hoppe M, Klose KJ. Rofo; 1997 May 25; 166(5):370-5. PubMed ID: 9198507 [Abstract] [Full Text] [Related]
17. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients. Wendt-Nordahl G, Rotert H, Trojan L, Michel MS, Peters CR, Alken P, Knoll T. Med Princ Pract; 2006 Aug 25; 15(5):358-61. PubMed ID: 16888393 [Abstract] [Full Text] [Related]
18. [Quality control in urography using non-ionic contrast media (iopamidol) and induced hydration]. Stacul F, Bazzocchi M, Zanella F, Abbona M. Radiol Med; 1986 Mar 25; 72(3):138-41. PubMed ID: 3704214 [Abstract] [Full Text] [Related]